|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Prediabetes | 12-Apr-1982 | active |
| Anemia | 12-Apr-1982 | active |
| Chronic sinusitis | 07-Sep-1979 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Ferrous sulfate 325 mg prolonged-release oral tablet | 1982-04-19 | - | 1 tablet (325 mg) by mouth once daily | - |
| Vitamin B12 5 MG/ML Injectable Solution | 1982-04-19 | - | 1 mL (5 mg) injected intramuscularly once monthly | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Streptococcus pneumoniae Danish serotype 1 | 05-May-2025 |
| Influenza virus antigen only vaccine product | 05-May-2025 |
| SARS-CoV-2 mRNA vaccine | 26-Apr-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 12-Apr-2021 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 24-Jan-2022 | - |
| Assessment of health and social care needs | 24-Jan-2022 | - |
| Assessment of anxiety | 24-Jan-2022 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 24-Jan-2022 | - |
| Patient evaluation and management | 26-Dec-2017 | - |
| Urine specimen collection | 26-Dec-2017 | - |
| Patient discharge | 26-Dec-2017 | - |
| Taking patient vital signs | 26-Dec-2017 | - |
| History taking | 26-Dec-2017 | - |
| Discussion about signs and symptoms | 26-Dec-2017 | - |
| Antibiotic therapy | 26-Dec-2017 | - |
| Triage: emergency center | 26-Dec-2017 | - |
| Urinalysis with reflex to microscopy and culture | 26-Dec-2017 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Diabetes self management plan | 12-Apr-1982 | Prediabetes |
|
||
| Immunization Recommendation | Due Date | Reason |
| Vaccine product containing only Influenza virus antigen (medicinal product) | 01-Oct-2025 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2025-05-05 | 2024-04-29 |
|---|---|---|
| Body Height | 169.7 cm | 169.7 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 3 {score} |
| Body Weight | 78.9 kg | 78.9 kg |
| Body mass index (BMI) [Ratio] | 27.4 kg/m2 | 27.4 kg/m2 |
| Diastolic Blood Pressure | 89 mm[Hg] | 84 mm[Hg] |
| Systolic Blood Pressure | 120 mm[Hg] | 125 mm[Hg] |
| Heart rate | 66 /min | 65 /min |
| Respiratory rate | 14 /min | 14 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 05-MAY-2025 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.0 | 4 - 6 | % |
| Glucose [Mass/volume] in Blood | 76.1 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 18.9 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.9 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.4 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 136.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.3 | 3.5 - 5 | mmol/L |
| Chloride [Moles/volume] in Blood | 104.3 | 98 - 110 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 20.4 L | 22 - 32 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 214.9 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 141.2 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 159.3 H | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 27.4 L | 40 - 60 | mg/dL |
Device Use
| Device | Date (since) |
|---|---|
| Blood glucose meter (physical object) | 12-Apr-1982 |
| Home nebulizer (physical object) | 07-Sep-1979 |